Search by Drug Name or NDC

    NDC 63868-0352-03 Aspirin 325 mg/1 Details

    Aspirin 325 mg/1

    Aspirin is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by CHAIN DRUG MARKETING ASSOCIATION INC. The primary component is ASPIRIN.

    Product Information

    NDC 63868-0352
    Product ID 63868-352_5a422ee0-d6b0-48df-b864-ec59bf22bcc7
    Associated GPIs 64100010000315
    GCN Sequence Number 004376
    GCN Sequence Number Description aspirin TABLET 325 MG ORAL
    HIC3 H3D
    HIC3 Description ANALGESIC/ANTIPYRETICS, SALICYLATES
    GCN 16701
    HICL Sequence Number 001820
    HICL Sequence Number Description ASPIRIN
    Brand/Generic Generic
    Proprietary Name Aspirin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aspirin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 325
    Active Ingredient Units mg/1
    Substance Name ASPIRIN
    Labeler Name CHAIN DRUG MARKETING ASSOCIATION INC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M013
    Listing Certified Through 2024-12-31

    Package

    NDC 63868-0352-03 (63868035203)

    NDC Package Code 63868-352-03
    Billing NDC 63868035203
    Package 300 TABLET, FILM COATED in 1 BOTTLE (63868-352-03)
    Marketing Start Date 1996-02-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.01106
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description QC ASPIRIN 325 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis